Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Accounts Payables (2020 - 2026)

Bioventus filings provide 6 years of Accounts Payables readings, the most recent being $10.9 million for Q4 2025.

  • On a quarterly basis, Accounts Payables fell 53.87% to $10.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.9 million, a 53.87% decrease, with the full-year FY2025 number at $10.9 million, down 53.87% from a year prior.
  • Accounts Payables hit $10.9 million in Q4 2025 for Bioventus, down from $26.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $41.4 million in Q3 2023 to a low of $9.9 million in Q3 2021.
  • Median Accounts Payables over the past 5 years was $20.8 million (2022), compared with a mean of $21.6 million.
  • Biggest five-year swings in Accounts Payables: surged 282.52% in 2021 and later crashed 53.87% in 2025.
  • Bioventus' Accounts Payables stood at $16.9 million in 2021, then surged by 116.95% to $36.7 million in 2022, then crashed by 37.22% to $23.0 million in 2023, then grew by 2.83% to $23.7 million in 2024, then crashed by 53.87% to $10.9 million in 2025.
  • The last three reported values for Accounts Payables were $10.9 million (Q4 2025), $26.6 million (Q3 2025), and $24.2 million (Q2 2025) per Business Quant data.